Tesla is shifting its residential solar strategy toward standard rooftop panels, pushing its Solar Roof tiles into a lower priority, an EV media outlet reported. Tesla has stopped disclosing Solar Roof installation figures and its new products and production expansion plans appear focused on conventional panels. The Solar Roof missed early targets and faced complaints over service, performance and costs, including a lawsuit over price increases. Recent announcements highlight new panel models and U.S. manufacturing expansion plans.

Eli Lilly\'s next-generation obesity treatment retatrutide may reduce fatigue, a side effect often associated with GLP-1 drugs, by regulating energy metabolism as well as suppressing appetite. Retatrutide is designed as a triple agonist that stimulates GLP-1, GIP and glucagon receptors. This mechanism could promote fat and glycogen breakdown while boosting insulin and limiting blood sugar spikes. Gigazine said clinical data are not yet sufficient to confirm the effect.